These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7190711)

  • 1. Calcium-dependent regulator involvement in the dopamine receptors supersensitivity.
    Lucchelli A
    Pharmacol Res Commun; 1980 Jul; 12(7):709-17. PubMed ID: 7190711
    [No Abstract]   [Full Text] [Related]  

  • 2. Cocaine-induced supersensitivity of striatal dopamine receptors: role of endogenous calmodulin.
    Memo M; Pradhan S; Hanbauer I
    Neuropharmacology; 1981 Dec; 20(12A):1145-50. PubMed ID: 7322289
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of calmodulin in dopaminergic transmission.
    Hanbauer I; Pradhan S; Yang HY
    Ann N Y Acad Sci; 1980; 356():292-303. PubMed ID: 6263151
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of calmodulin in states of altered catecholamine sensitivity.
    Gnegy ME; Lau YS; Treisman G
    Ann N Y Acad Sci; 1980; 356():304-18. PubMed ID: 6786156
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
    Jenner P; Elliott PN; Clow A; Reavill C; Marsden CD
    J Pharm Pharmacol; 1978 Jan; 30(1):46-8. PubMed ID: 22724
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
    Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
    Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine administration: D1 dopamine receptor function and dopamine clearance/diffusion in rat striatum and nucleus accumbens.
    Zahniser NR; Mayfield RD; Cass WA; Gerhardt GA
    Ann N Y Acad Sci; 1992 Jun; 654():537-9. PubMed ID: 1385936
    [No Abstract]   [Full Text] [Related]  

  • 10. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
    [No Abstract]   [Full Text] [Related]  

  • 11. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
    Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 13. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
    Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
    Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum.
    Garau L; Govoni S; Stefanini E; Trabucchi M; Spano PF
    Life Sci; 1978 Oct; 23(17-18):1745-50. PubMed ID: 723447
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
    Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.
    Pycock CJ; Kerwin RW; Carter CJ
    Nature; 1980 Jul; 286(5768):74-6. PubMed ID: 7393327
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic sulpiride increased 3H-spiperone binding and calmodulin dependent phosphorylation in rat striatum.
    Lau YS; Runice C; Dowd FJ; Anene C
    Proc West Pharmacol Soc; 1983; 26():139-43. PubMed ID: 6310625
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 59(3):211-6. PubMed ID: 32570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.